US2019055569A1PendingUtilityA1

Compositions and methods for bacterial delivery of polypeptides

Assignee: MASSACHUSETTS GEN HOSPITALPriority: Mar 7, 2013Filed: Mar 9, 2018Published: Feb 21, 2019
Est. expiryMar 7, 2033(~6.6 yrs left)· nominal 20-yr term from priority
A61P 37/06A61P 35/00A61P 29/00A61P 3/04C12N 15/70A61K 35/74A61K 48/00C12N 15/74A61P 1/04A61P 11/06
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The methods and compositions described herein relate to the delivery of polypeptides to a target cell, e.g. by utilizing engineered non-pathogenic bacteria comprising a type three secretion system (T3SS) and T3SS-compatible substrates. In one aspect, described herein are non-pathogenic microbial cells that have been engineered to express both a functional type three secretion system (T3SS) and at least one polypeptide that is compatible with the T3SS. Due to the wide variety of polypeptides that can be delivered to a target eukaryotic cell using the compositions and systems described herein, a commensurately wide variety of applications is contemplated, e.g. therapeutics and reprogramming.

Claims

exact text as granted — not AI-modified
1 . An engineered non-pathogenic microbial cell comprising:
 a first nucleic acid sequence comprising genes encoding a functional type three secretion system (T3SS);   a second nucleic acid sequence encoding an T3SS-compatible polypeptide;   wherein the engineered microbial cell is non-pathogenic with respect to the target cell or target organism.   
     
     
         2 .- 56 . (canceled)

Join the waitlist — get patent alerts

Track US2019055569A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.